A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs

[11] Franzo G(2016)Impact of maternally derived immunity on piglets’ immune response and protection against porcine circovirus type 2 (PCV-2) after vaccination against PCV2 at different age BMC Vet Res 12 77-3050

[12] Cortey M(2012)Effect of sow and piglet porcine circovirus type 2 (PCV-2) vaccination on piglet mortality, viraemia, antibody titre and production parameters Vet Microbiol 161 229-462

[13] Olvera A(2012)Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity Vaccine 30 1986-280

[14] Novosel D(2014)Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV-2) single-dose vaccines on pigs under experimental PCV2 challenge Vet Microbiol 172 371-3607

[15] De Castro AMMG(2016)Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV-2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions Vaccine 34 3044-505

[16] Biagini P(1973)Enzootic pneumonia of pigs: immunisation attempts inoculating M. Suipneumoniae antigen by various routes and with different adjuvants Brit Vet J 129 456-1034

[17] Fort M(2014)Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies Vet Microbiol 168 272-120

[18] Sibila M(2003)Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infection in vaccinated pigs Vaccine 21 3601-282

[19] Pérez-Martín E(2015)Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm PHM 1 15-89

[20] Nofrarías M(1998)Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system J Veterinary Med Ser B 45 495-215

[11] Franzo G(2016)Impact of maternally derived immunity on piglets’ immune response and protection against porcine circovirus type 2 (PCV-2) after vaccination against PCV2 at different age BMC Vet Res 12 77-3050

[12] Cortey M(2012)Effect of sow and piglet porcine circovirus type 2 (PCV-2) vaccination on piglet mortality, viraemia, antibody titre and production parameters Vet Microbiol 161 229-462

[13] Olvera A(2012)Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity Vaccine 30 1986-280

[14] Novosel D(2014)Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV-2) single-dose vaccines on pigs under experimental PCV2 challenge Vet Microbiol 172 371-3607

[15] De Castro AMMG(2016)Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV-2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions Vaccine 34 3044-505

[16] Biagini P(1973)Enzootic pneumonia of pigs: immunisation attempts inoculating M. Suipneumoniae antigen by various routes and with different adjuvants Brit Vet J 129 456-1034

[17] Fort M(2014)Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies Vet Microbiol 168 272-120

[18] Sibila M(2003)Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infection in vaccinated pigs Vaccine 21 3601-282

[19] Pérez-Martín E(2015)Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm PHM 1 15-89

[20] Nofrarías M(1998)Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system J Veterinary Med Ser B 45 495-215